Japanese firms ink new business partnership worth ¥5 B for mental healthcare

Japan |  News | 0 Comment | 02 Feb, 2022

With the aim of building a regional cooperative mental health platform, Jolly Good Inc. and Otsuka Pharmaceutical h...Read more

Japan grants patent to Anixa Biosciences for ovarian cancer vaccine

Japan |  News | 0 Comment | 01 Feb, 2022

US-based Anixa Biosciences, Inc. has announced that the Japanese Patent Office has issued a Decision to Grant ...Read more

Daiichi Sankyo starts trial for mRNA vaccine as booster dose in Japan

Japan |  News | 0 Comment | 31 Jan, 2022

Daiichi Sankyo has initiated a trial in Japan to investigate a booster dose of DS-5670, an mRNA vaccine against COVID-19...Read more

Japan's Fujifilm buys Atara’s T-cell manufacturing facility for $100 M

Japan |  News | 0 Comment | 27 Jan, 2022

Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies...Read more

Illumina collaborates with National Cancer Center Japan

Japan |  News | 0 Comment | 25 Jan, 2022

Illumina, Inc. and the National Cancer Center Japan have announced an international joint research project that wil...Read more

Japan approves VYVGART for treatment of generalised Myasthenia Gravis

Japan |  News | 1 Comment | 20 Jan, 2022

Netherlands-based argenx SE has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved ...Read more

Japan’s Daiichi Sankyo divests certain cardiovascular products, shifting focus to oncology

Japan |  News | 0 Comment | 19 Jan, 2022

Japan-based pharmaceutical firm Daiichi Sankyo has entered into an agreement with Cosette Pharmaceuticals, Inc. whereby ...Read more

IQVIA releases emerging biotech/biopharma trends to watch for in 2022

Japan |  News | 0 Comment | 19 Jan, 2022

IQVIA has come up with the key trends that emerging biotech and emerging biopharma companies should look out for in 2022...Read more

Japan approves MicroPort CRM's Alizea Bluetooth Pacemaker

Japan |  News | 0 Comment | 17 Jan, 2022

MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, has recentl...Read more

Japan’s Takeda buys Adaptate Biotherapeutics to strengthen immuno-oncology portfolio

Japan |  News | 0 Comment | 11 Jan, 2022

Takeda Pharmaceutical Company has announced the exercise of its option to acquire Adaptate Biotherapeutics, a UK-based c...Read more

Japan develops cancer therapy using on-site synthesis of anti-cancer drugs

Japan |  News | 0 Comment | 10 Jan, 2022

An international research group at the RIKEN Cluster for Pioneering Research (CPR) in Japan has successfully treated can...Read more

Japan’s Otsuka Pharma invests in development of psychedelic medicines

Japan |  News | 0 Comment | 07 Jan, 2022

The McQuade Center for Strategic Research and Development, LLC (MSRD), established in the US by Japan-based Otsuka Pharm...Read more

Japan's Shimadzu enters into 'smart cells' field with new investment

Japan |  News | 0 Comment | 06 Jan, 2022

Japan-based Shimadzu Corporation has invested in Bacchus Bio innovation, a startup company spun off from Kobe University...Read more

Japan's PRISM BioLab partners with Roche and Genentech for drug discovery research

Japan |  News | 0 Comment | 05 Jan, 2022

PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...Read more

Japan opts for drug repurposing to stop dementia

Japan |  News | 0 Comment | 01 Jan, 2022

Via drug repositioning, a team of scientists at the Osaka City University in Japan has created a combination of rifampic...Read more

Japan-funded study explores antibodies to neutralise omicron

Japan |  News | 0 Comment | 28 Dec, 2021

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. Th...Read more

Merck and Ridgeback’s COVID-19 pill receives ‘special approval’ in Japan

Japan |  News | 0 Comment | 27 Dec, 2021

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...Read more

Eisai to market Gilead’s rheumatoid arthritis drug in Asia

Japan |  News | 0 Comment | 23 Dec, 2021

Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...Read more